68Gallium prostate specific membrane antigen (PSMA) ligand positron emission tomography (PET) is an increasingly used imaging modality in prostate cancer, especially in cases of tumor recurrence after curative intended therapy. Owed to the novelty of the PSMA-targeting tracers, clinical evidence on the value of PSMA-PET is moderate but rapidly increasing. State of the art imaging is pivotal for radiotherapy treatment planning as it may affect dose prescription, target delineation and use of concomitant therapy.This review summarizes the evidence on PSMA-PET imaging from a radiation oncologist’s point of view. Additionally a short survey containing twelve examples of patients and 6 additional questions was performed in seven mayor academic centers with experience in PSMA ligand imaging and the findings are reported here.Electronic supplementary materialThe online version of this article (10.1186/s13014-018-1047-5) contains supplementary material, which is available to authorized users.
Pancreatic neuroendocrine neoplasms (pNEN) are rare malignancies arising from neuroendocrine cells of the pancreas. Functional tumors can present with specific clinical syndromes due to hormonal secretion. These tumors can present as incidental findings on imaging performed for unrelated purposes or they are diagnosed when workup is initiated in patients with specific syndromes or metastases. This article presents an overview of available imaging techniques focusing on computed tomography and magnetic resonance imaging. Recommendations regarding examination protocols are given. Typical imaging features of pNEN and metastases are described. Their potential value for the evaluation of prognosis as well as tumor response under treatment is discussed.
Lymphatic spread determines treatment decisions in prostate cancer (PCa) patients. 68Ga-PSMA-PET/ ct can be performed, although cost remains high and availability is limited. therefore, computed tomography (ct) continues to be the most used modality for pca staging. We assessed if convolutional neural networks (CNNs) can be trained to determine 68Ga-PSMA-PET/CT-lymph node status from CT alone. In 549 patients with 68Ga-PSMA PET/CT imaging, 2616 lymph nodes were segmented. Using PET as a reference standard, three CNNs were trained. Training sets balanced for infiltration status, lymph node location and additionally, masked images, were used for training. cnns were evaluated using a separate test set and performance was compared to radiologists' assessments and random forest classifiers. Heatmaps maps were used to identify the performance determining image regions. The CNNs performed with an Area-Under-the-Curve of 0.95 (status balanced) and 0.86 (location balanced, masked), compared to an AUC of 0.81 of experienced radiologists. Interestingly, CNNs used anatomical surroundings to increase their performance, "learning" the infiltration probabilities of anatomical locations. in conclusion, cnns have the potential to build a well performing ct-based biomarker for lymph node metastases in PCa, with different types of class balancing strongly affecting cnn performance. Prostate cancer (PCa) is the most common malignant cancer in men worldwide, and the second most common cause of cancer related death in men 1. Patients with intermediate or high-risk PCa undergo regular staging examinations in order to determine if the tumor has spread beyond the prostate. As treatment success is highly dependent on the presence of systemic spread 2,3 , staging procedures with high sensitivity and specificity are necessary. Standard of care imaging for PCa staging typically includes contrast-enhanced computed tomography (CT) and Technetium-99m-methylene diphosphonate bone scans 4,5. Despite the continued recommendation of CT in staging, it has been shown that predicting lymph node infiltration (LNI) with CT scans is not very reliable 6,7 , with one study reporting a sensitivity and specificity of only 42% and 82% 8. This low performance is most likely due to the limited morphological criteria used to define a lymph node as positive for infiltration, with size being the most relevant 9. A threshold of 8-10 mm is often used despite the fact that 80% of lymph node metastases are less than 8 mm in the short axis 10. Further criteria, such as status of hilum fat, nodal shape, and enhancement characteristics are used to aid diagnosis, but it remains difficult to exclude LNI in large benign hyperplastic nodes or detect it in small nodes below the size threshold 11. In 2012 imaging agents binding to Prostate Specific Membrane Antigen (PSMA) were introduced, leading to the development of PSMA PET/CT 8. PSMA, an integral membrane glycoprotein expressed 100-1000 fold on membranes of PCa cells compared to prostate cells, has been shown to correlate ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.